Tandem Diabetes Secures $52 Million in Series C Funding

Advised Tandem Diabetes, a designer and manufacturer of durable insulin pumps for individuals with diabetes, in its $52 million Series C  funding from LM Venture Partners, Domain Associates, TPG, Delphi Ventures, and Kearny Venture Partners on January 7, 2010, putting the company's pre-money valuation at $44 million.